Dr Lenze of Washington University St. Louis Talks Antidepressant Fluvoxamine Covid-19 Clinical Trial

Dr. Lenze discusses a clinical trial conducted by Washington University School of Medicine in St. Louis which evidences the potential that fluvoxamine, an antidepressant, may prevent COVID-19 infections from worsening. This trial is based on recent research that originates from the University of Virginia School of Medicine.

Website: https://stopcovidtrial.wustl.edu/

Phone: 314-747-1137

Email: stopcovidtrial@wustl.edu